{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:01:07Z","timestamp":1786122067544,"version":"build-2736575974"},"reference-count":52,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of clinically aggressive mature T-cell and natural killer (NK)-cell neoplasms that account for approximately 10\u201315% of all non-Hodgkin lymphomas in Western countries . The most common subtypes include extranodal NK\/T-cell lymphoma (ENKTL), nodal T-follicular helper cell lymphomas, peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), anaplastic large cell lymphoma (ALK-positive and ALK-negative), and T-cell lymphoblastic lymphoma. Non-coding RNAs (ncRNAs) constitute the majority of the human transcriptome and play critical roles in regulating gene expression, cellular proliferation, differentiation, migration, and apoptosis. Among these, long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) have emerged as key regulators of lymphomagenesis and disease progression in PTCLs. These molecules modulate diverse oncogenic pathways through chromatin remodeling, transcriptional regulation, competing endogenous RNA activity, and interactions with RNA-binding proteins, thereby influencing proliferation, immune evasion, treatment resistance, and clinical outcomes. Representative examples include the lncRNA TCLlnc1, which promotes PTCL progression through activation of transforming growth factor-\u03b2 (TGF-\u03b2) signaling, and the circRNAs circKIF4A, circADARB1, and circ-LAMP1, which regulate miRNA-dependent signaling networks involving PDK1\/BCL11A, STAT3, and DDR2, respectively. In this review, we summarize the current understanding of the biological and clinical roles of lncRNAs and circRNAs in PTCL and related T-cell and NK-cell neoplasms and highlight their potential as diagnostic and prognostic biomarkers as well as therapeutic targets. We also discuss recent advances and future directions for integrating ncRNA-based approaches into precision medicine for T-cell lymphoma.<\/jats:p>","DOI":"10.3390\/cancers18162535","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:01:36Z","timestamp":1786089696000},"page":"2535","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long Non-Coding RNAs and Circular RNAs in the Pathobiology of T-Cell Lymphoma"],"prefix":"10.3390","volume":"18","author":[{"given":"Shahed Azzam Ahmed","family":"Abdullah","sequence":"first","affiliation":[{"name":"Department of Histopathology, Trinity College Dublin, D02 PN40 Dublin, Ireland"},{"name":"Division of Hematology and Oncology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4993-4563","authenticated-orcid":false,"given":"Richard","family":"Flavin","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Trinity College Dublin, D02 PN40 Dublin, Ireland"},{"name":"Department of Histopathology, St. James\u2019s Hospital, D08 NHY1 Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.seminhematol.2023.07.003","article-title":"Circulating tumor DNA in NK\/T and peripheral T cell lymphoma","volume":"60","author":"Huo","year":"2023","journal-title":"Semin. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41379-021-00937-0","article-title":"Genetic profiling and biomarkers in peripheral T-cell lymphomas: Current role in the diagnostic work-up","volume":"35","author":"Vega","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/cai2.28","article-title":"Circular RNAs: Biomarkers of cancer","volume":"1","author":"Cui","year":"2022","journal-title":"Cancer Innov."},{"key":"ref_4","first-page":"101550","article-title":"Extranodal NK\/T-cell lymphoma: An update of the molecular characterization of the tumor and microenvironment, and its clinical implications","volume":"62","author":"Chan","year":"2025","journal-title":"Lancet Reg. Health West. Pac."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: A report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.it.2023.07.006","article-title":"RNA circuits and RNA-binding proteins in T cells","volume":"44","author":"Zhu","year":"2023","journal-title":"Trends Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00262-025-04176-z","article-title":"Circular RNAs in cancer: Its biogenesis, functions, relationships with cancer progression, applications in immunotherapy and biomarker potentials","volume":"75","author":"Gao","year":"2026","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12964-024-01724-5","article-title":"piRNA associates with immune diseases","volume":"22","author":"Jiang","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13046-020-01727-3","article-title":"Long noncoding RNA: A dazzling dancer in tumor immune microenvironment","volume":"39","author":"Zhang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2019.05.007","article-title":"Role of long non-coding RNAs in lymphoma: A systematic review and clinical perspectives","volume":"141","author":"Yang","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Liu, Z., Dong, H., Ye, C., Yan, J., Miao, M., and Shao, Y. (2025). Small non-coding RNAs: Key regulatory factors and potential therapeutic targets in tumor immunity. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1639763"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yao, J., Xie, M., Ma, X., Song, J., Wang, Y., and Xue, X. (2022). PIWI-interacting RNAs in cancer: Biogenesis, function, and clinical significance. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.965684"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.gendis.2021.02.001","article-title":"Long noncoding RNAs (lncRNAs) in human lymphomas","volume":"9","author":"Gholami","year":"2022","journal-title":"Genes. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.3324\/haematol.2022.282552","article-title":"Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: A novel regulator of mitophagy in T-cell lymphoma","volume":"108","author":"Mularoni","year":"2023","journal-title":"Haematologica"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"C415","DOI":"10.1152\/ajpcell.00069.2020","article-title":"lncRNAs in T lymphocytes: RNA regulation at the heart of the immune response","volume":"320","author":"Plasek","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.gene.2019.03.052","article-title":"Circ-LAMP1 promotes T-cell lymphoblastic lymphoma progression via acting as a ceRNA for miR-615-5p to regulate DDR2 expression","volume":"701","author":"Deng","year":"2019","journal-title":"Gene"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41419-021-03594-y","article-title":"A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/s12935-021-02296-x","article-title":"CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3","volume":"21","author":"Mei","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"He, R., Wen, W., Fu, B., Zhu, R., Chen, G., Bai, S., Cao, X., and Wang, H. (2022). CircKIF4A Is a Prognostic Factor and Modulator of Natural Killer\/T-Cell Lymphoma Progression. Cancers, 14.","DOI":"10.3390\/cancers14194950"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41571-018-0035-x","article-title":"Clinical utility of circulating non-coding RNAs\u2014An update","volume":"15","author":"Anfossi","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"pbag011","DOI":"10.1093\/pcmedi\/pbag011","article-title":"Circular RNA as emerging precision therapeutics: From RNA regulation to peptide translation","volume":"9","author":"Wu","year":"2026","journal-title":"Precis. Clin. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"101833","DOI":"10.1016\/j.gendis.2025.101833","article-title":"The role of long non-coding RNAs in NK cell biology and diseases","volume":"13","author":"Zhang","year":"2026","journal-title":"Genes. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Piccaluga, P.P., and Khattab, S.S. (2023). A Comparison of the Fifth World Health Organization and the International Consensus Classifications of Mature T-Cell Lymphomas. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241814170"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.gendis.2020.08.006","article-title":"MiRNAs and lncRNAs in NK cell biology and NK\/T-cell lymphoma","volume":"8","author":"Gao","year":"2021","journal-title":"Genes. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"31305","DOI":"10.18632\/oncotarget.15453","article-title":"Association of the long non-coding RNA MALAT1 with the polycomb repressive complex pathway in T and NK cell lymphoma","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3324\/haematol.2017.181966","article-title":"Blockade of crizotinib-induced BCL2 elevation in ALK-positive anaplastic large cell lymphoma triggers autophagy associated with cell death","volume":"104","author":"Torossian","year":"2019","journal-title":"Haematologica"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/bs.ircmb.2023.04.004","article-title":"Non-coding RNAs in the epigenetic landscape of cutaneous T-cell lymphoma","volume":"380","author":"Adeeb","year":"2023","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/s41418-022-01022-y","article-title":"Targeting mitochondrial metabolism for precision medicine in cancer","volume":"29","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13046-022-02439-6","article-title":"Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: A review","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1158\/1078-0432.CCR-04-1785","article-title":"Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer","volume":"11","author":"Akada","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1038\/sj.onc.1208642","article-title":"Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis","volume":"24","author":"Erkan","year":"2005","journal-title":"Oncogene"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Chen, Q., Zhu, C., and Jin, Y. (2020). The Oncogenic and Tumor Suppressive Functions of the Long Noncoding RNA MALAT1: An Emerging Controversy. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.00093"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-023-05647-w","article-title":"Regulation of the tumor immune microenvironment by cancer-derived circular RNAs","volume":"14","author":"Guan","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13045-020-00976-1","article-title":"The functions and clinical significance of circRNAs in hematological malignancies","volume":"13","author":"Zhou","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/leu.2009.91","article-title":"STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK\/T-cell lymphoma","volume":"23","author":"Coppo","year":"2009","journal-title":"Leukemia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2478\/s11658-010-0008-2","article-title":"STAT3 knockdown by siRNA induces apoptosis in human cutaneous T-cell lymphoma line Hut78 via downregulation of Bcl-xL","volume":"15","author":"Verma","year":"2010","journal-title":"Cell Mol. Biol. Lett."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1309\/FNY8Y4H6PK1V2MGE","article-title":"Expression of anaplastic lymphoma kinase, tyrosine-phosphorylated STAT3, and associated factors in pediatric anaplastic large cell lymphoma: A report from the children\u2019s oncology group","volume":"127","author":"Nasr","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_43","first-page":"3219","article-title":"JAK3\/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK\/T-cell lymphoma, nasal type","volume":"41","author":"Liu","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.62347\/KMWB5164","article-title":"Molecular significance of circRNAs in malignant lymphoproliferative disorders: Pathogenesis and novel biomarkers or therapeutic targets","volume":"14","author":"Long","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Du, J., Jia, F., and Wang, L. (2022). Advances in the Study of circRNAs in Hematological Malignancies. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.900374"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1186\/s12967-024-05562-4","article-title":"CircRNA as an Achilles heel of cancer: Characterization, biomarker and therapeutic modalities","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"155769","DOI":"10.1016\/j.prp.2024.155769","article-title":"MicroRNAs and long non-coding RNAs In T-cell lymphoma: Mechanisms, pathway, therapeutic opportunities","volume":"266","author":"Abalkhail","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Prasad, S., Adivikolanu, H., Banerjee, A., Mittal, M., Lemos, J.R.N., Mittal, R., and Hirani, K. (2025). The role of microRNAs and long non-coding RNAs in epigenetic regulation of T cells: Implications for autoimmunity. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1695894"},{"key":"ref_49","first-page":"7","article-title":"Unlocking the potential of engineered circular RNA therapeutics","volume":"4","author":"Zhen","year":"2026","journal-title":"Med. X"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"114696","DOI":"10.1016\/j.intimp.2025.114696","article-title":"The lncRNA LINC02446 promotes tumor progression and HLH occurrence by regulating the expression of KLRs and IL-10 in EBV-NK-LPDs","volume":"156","author":"Ma","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1038\/s41388-026-03868-9","article-title":"LncRNA IRENA promotes peripheral T-cell lymphoma progression through scaffolding ARHGEF1 and FMNL1 to modulate RHOA GTPase\/MAPK signaling","volume":"45","author":"Wang","year":"2026","journal-title":"Oncogene"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Babin, L., Andraos, E., Fuchs, S., Bessi\u00e8re, C., Colras, L., Dailhau, S., Quelen, C., Pinto, C., Daoudi, I., and Pfeifer, R. (2026). CircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas. Leukemia, 1\u201313.","DOI":"10.64898\/2026.01.13.699235"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2535\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:15:30Z","timestamp":1786090530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":52,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cancers18162535"],"URL":"https:\/\/doi.org\/10.3390\/cancers18162535","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}